Association Between Low Relative Muscle Mass and the Risk of Colorectal Neoplasms
暂无分享,去创建一个
[1] W. Zheng,et al. Evaluation of pro‐inflammatory markers plasma C‐reactive protein and urinary prostaglandin‐E2 metabolite in colorectal adenoma risk , 2016, Molecular carcinogenesis.
[2] K. Fearon,et al. Low Muscularity and Myosteatosis Is Related to the Host Systemic Inflammatory Response in Patients Undergoing Surgery for Colorectal Cancer , 2016, Annals of surgery.
[3] Zhiyan Yu,et al. Sarcopenia, as defined by low muscle mass, strength and physical performance, predicts complications after surgery for colorectal cancer , 2015, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.
[4] E. Giovannucci,et al. Plasma Inflammatory Markers and Risk of Advanced Colorectal Adenoma in Women , 2015, Cancer Prevention Research.
[5] S. Jeon,et al. Is Retroflexion Helpful in Detecting Adenomas in the Right Colon?: A Single Center Interim Analysis , 2015, Intestinal research.
[6] E. Kang,et al. Sarcopaenia is associated with NAFLD independently of obesity and insulin resistance: Nationwide surveys (KNHANES 2008-2011). , 2015, Journal of hepatology.
[7] S. Park,et al. Inhibitory Effect of Metformin Therapy on the Incidence of Colorectal Advanced Adenomas in Patients With Diabetes , 2015, Intestinal research.
[8] K. Fearon,et al. The role of body composition evaluation by computerized tomography in determining colorectal cancer treatment outcomes: a systematic review. , 2015, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[9] J. Cha,et al. Impact of Sigmoidoscopy and Colonoscopy on Colorectal Cancer Incidence and Mortality: An Evidence-Based Review of Published Prospective and Retrospective Studies , 2014, Intestinal research.
[10] Luigi Ferrucci,et al. Age-related and disease-related muscle loss: the effect of diabetes, obesity, and other diseases. , 2014, The lancet. Diabetes & endocrinology.
[11] O. Faiz,et al. A Preoperative Neutrophil to Lymphocyte Ratio of 3 Predicts Disease-Free Survival After Curative Elective Colorectal Cancer Surgery , 2014, Annals of surgery.
[12] Tao Xi,et al. C-reactive protein, interleukin-6 and the risk of colorectal cancer: a meta-analysis , 2014, Cancer Causes & Control.
[13] H. J. Yoo,et al. Relationship between sarcopenia and nonalcoholic fatty liver disease: The Korean Sarcopenic Obesity Study , 2014, Hepatology.
[14] Young Sun Kim,et al. Physical activity and other lifestyle factors in relation to the prevalence of colorectal adenoma: a colonoscopy-based study in asymptomatic Koreans , 2013, Cancer Causes & Control.
[15] Constance M. Johnson,et al. Meta-analyses of colorectal cancer risk factors , 2013, Cancer Causes & Control.
[16] S. Wong,et al. Colorectal cancer screening in Asia. , 2013, British medical bulletin.
[17] T. Fukui,et al. The association between obesity and colorectal adenoma: systematic review and meta-analysis , 2013, Scandinavian journal of gastroenterology.
[18] Yongzhi Yang,et al. Obesity and Risk of Colorectal Cancer: A Systematic Review of Prospective Studies , 2013, PloS one.
[19] S. Liangpunsakul,et al. The Association Between Metabolic Syndrome and Colorectal Neoplasm: Systemic Review and Meta-analysis , 2013, Journal of clinical gastroenterology.
[20] Douglas K Rex,et al. Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer. , 2012, Gastroenterology.
[21] D. McMillan,et al. The Relationships between Body Composition and the Systemic Inflammatory Response in Patients with Primary Operable Colorectal Cancer , 2012, PloS one.
[22] H. J. Yoo,et al. Association Between Visceral Obesity and Sarcopenia and Vitamin D Deficiency in Older Koreans: The Ansan Geriatric Study , 2012, Journal of the American Geriatrics Society.
[23] B. Spiegelman,et al. Molecular mechanisms of cancer development in obesity , 2011, Nature Reviews Cancer.
[24] A. Karlamangla,et al. Relative muscle mass is inversely associated with insulin resistance and prediabetes. Findings from the third National Health and Nutrition Examination Survey. , 2011, The Journal of clinical endocrinology and metabolism.
[25] E. Riboli,et al. Meta-Analyses of Vitamin D Intake, 25-Hydroxyvitamin D Status, Vitamin D Receptor Polymorphisms, and Colorectal Cancer Risk , 2011, Cancer Epidemiology, Biomarkers & Prevention.
[26] David Scott,et al. A prospective study of the associations between 25‐hydroxy‐vitamin D, sarcopenia progression and physical activity in older adults , 2010, Clinical endocrinology.
[27] H. J. Yoo,et al. Prevalence and determinant factors of sarcopenia in patients with type 2 diabetes: The Korean Sarcopenic Obesity Study (KSOS) (Diabetes Care (2010) 33, (1497-1499)) , 2010 .
[28] K. Park,et al. Sarcopenic Obesity: Prevalence and Association With Metabolic Syndrome in the Korean Longitudinal Study on Health and Aging (KLoSHA) , 2010, Diabetes Care.
[29] J. Baeyens,et al. Sarcopenia: European consensus on definition and diagnosis , 2010, Age and ageing.
[30] Chih-Cheng Hsu,et al. Are Asians at greater mortality risks for being overweight than Caucasians? Redefining obesity for Asians , 2009, Public Health Nutrition.
[31] A. Muñoz,et al. Vitamin D and Wnt/beta-catenin pathway in colon cancer: role and regulation of DICKKOPF genes. , 2008, Anticancer research.
[32] B. Edwards,et al. Colorectal cancer in U.S. adults younger than 50 years of age, 1998–2001 , 2006, Cancer.
[33] M. Visser,et al. Inflammatory markers and loss of muscle mass (sarcopenia) and strength. , 2006, The American journal of medicine.
[34] W. Bilker,et al. Fluoroquinolone-resistant Pseudomonas aeruginosa: assessment of risk factors and clinical impact. , 2006, The American journal of medicine.
[35] W. R. Bruce,et al. Hyperinsulinemia, but not other factors associated with insulin resistance, acutely enhances colorectal epithelial proliferation in vivo. , 2006, Endocrinology.
[36] R. Krauss,et al. Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement , 2005, Current opinion in cardiology.
[37] Marjolein Visser,et al. Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): the Longitudinal Aging Study Amsterdam. , 2003, The Journal of clinical endocrinology and metabolism.
[38] M. Malavolti,et al. Cross-calibration of eight-polar bioelectrical impedance analysis versus dual-energy X-ray absorptiometry for the assessment of total and appendicular body composition in healthy subjects aged 21-82 years , 2003, Annals of human biology.
[39] Robert Ross,et al. Low Relative Skeletal Muscle Mass (Sarcopenia) in Older Persons Is Associated with Functional Impairment and Physical Disability , 2002, Journal of the American Geriatrics Society.
[40] A. Newman,et al. Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: the Health ABC Study. , 2002, The journals of gerontology. Series A, Biological sciences and medical sciences.
[41] C. Paraskeva,et al. Apoptosis is induced by the active metabolite of vitamin D3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: possible implications for prevention and therapy. , 2000, Cancer research.
[42] W. Willett,et al. Physical activity, obesity, and risk of colorectal adenoma in women (United States) , 1996, Cancer Causes & Control.
[43] Geerard L Beets,et al. Functional compromise reflected by sarcopenia, frailty, and nutritional depletion predicts adverse postoperative outcome after colorectal cancer surgery. , 2015, Annals of surgery.
[44] John T. Woosley,et al. Circulating levels of inflammatory cytokines and risk of colorectal adenomas. , 2008, Cancer research.